- Interactive Learning Program
Prescribing Information
Important Risk Information
References- Click each above to REVIEW or see below.
THANK YOU
for participating in this program!
1 of 4
Now that you’ve completed this Interactive Learning Program about ASTEPRO® (azelastine HCl) Nasal Spray 0.15%, you can choose either a $25 Elsevier Health Science certificate or a $25 Total Health Rewards certificate, for an educational item—courtesy of Meda Pharmaceuticals, Inc.*
* Your selected educational-item certificate will be sent via email, unless otherwise specified. You may opt not to receive an educational-item certificate. Receipt of this offer may be reported per laws of Massachusetts, Maine, West Virginia, and the District of Columbia. Healthcare professionals practicing in Minnesota and Vermont are not eligible to receive this offer. This offer is void where prohibited by law.
Indication for ASTEPRO® 0.15%
ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Important Risk Information
- Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
- Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
- In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
- Pregnancy Category C: Based on animal data, may cause fetal harm
Please see full Prescribing Information.
© 2012 Meda Pharmaceuticals Inc. All rights reserved. AST-12-0004